Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
Clinical trial NCT00447642 · TERMINATED
Trial details
- NCT number
- NCT00447642
- Sponsor
- Lux Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-08-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.